OssDsign AB (publ) initiates commercial preparations for launch in Japan following regulatory filing for OssDsign Cranial
OssDsign AB (publ) (”OssDsign” or the ”Company”), the Swedish designer and manufacturer of innovative implants for bone regeneration has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial planning for a market entry in Japan.OssDsign has, as previously communicated, spent a significant amount of time and resources in order to compile a regulatory submission for Japan. This work has required further pre-clinical testing in order to comply with the stringent Japanese requirements. The complete file was submitted on June